Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningitis | 1 | 2023 | 217 | 0.800 |
Why?
|
| Technology | 1 | 2023 | 292 | 0.190 |
Why?
|
| Septal Occluder Device | 1 | 2022 | 125 | 0.190 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2021 | 63 | 0.180 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 217 | 0.170 |
Why?
|
| Metagenomics | 1 | 2023 | 467 | 0.170 |
Why?
|
| Trypanosoma brucei brucei | 2 | 2016 | 45 | 0.160 |
Why?
|
| Methionine-tRNA Ligase | 1 | 2018 | 2 | 0.160 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 973 | 0.150 |
Why?
|
| Antiprotozoal Agents | 1 | 2016 | 94 | 0.130 |
Why?
|
| Infant, Premature, Diseases | 1 | 2022 | 710 | 0.130 |
Why?
|
| Drug-Eluting Stents | 1 | 2021 | 681 | 0.120 |
Why?
|
| Aorta, Thoracic | 1 | 2021 | 1096 | 0.120 |
Why?
|
| Trypanosomiasis, African | 1 | 2014 | 30 | 0.110 |
Why?
|
| Trypanocidal Agents | 1 | 2014 | 41 | 0.110 |
Why?
|
| Drug Design | 1 | 2018 | 1048 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 1927 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3639 | 0.090 |
Why?
|
| Benzamides | 1 | 2016 | 1371 | 0.090 |
Why?
|
| Imidazoles | 1 | 2014 | 1180 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 1914 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 3627 | 0.060 |
Why?
|
| Biological Availability | 2 | 2016 | 390 | 0.060 |
Why?
|
| Pyridines | 1 | 2014 | 2875 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 3076 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 80647 | 0.040 |
Why?
|
| Trypanosomiasis | 1 | 2016 | 8 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2016 | 4021 | 0.040 |
Why?
|
| Crystallization | 1 | 2018 | 534 | 0.030 |
Why?
|
| Catalysis | 1 | 2018 | 774 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2018 | 705 | 0.030 |
Why?
|
| Child | 1 | 2023 | 80158 | 0.030 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2014 | 13 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2014 | 173 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 1990 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 2107 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2014 | 575 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2022 | 26202 | 0.020 |
Why?
|
| Biopsy | 1 | 2022 | 6766 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2018 | 3968 | 0.020 |
Why?
|
| Dogs | 1 | 2014 | 3839 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1051 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5439 | 0.020 |
Why?
|
| Humans | 5 | 2023 | 761596 | 0.020 |
Why?
|
| Liver | 1 | 2022 | 7528 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9353 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8181 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 36193 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 29890 | 0.010 |
Why?
|
| Mice | 2 | 2016 | 81539 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54423 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 23741 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20568 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16990 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 64685 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 168475 | 0.010 |
Why?
|
| Female | 2 | 2021 | 392705 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 221210 | 0.000 |
Why?
|
| Male | 1 | 2021 | 360846 | 0.000 |
Why?
|
Concepts
(59)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_